Etelcacetide (CAS: 1262780-97-1)

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Etelcacetide Secondary hyperparathyroidism(HPT) Amgen  Feb. 7,2031


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us